your badges 52W Range $12–$30 51% of range Analyst Rating BUY 20 analysts Price Target $36 +72% upside P/E -8.2 ROE -64.0% Net Profit Margin -3060.0%

IMNM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $20.90
Market Cap (MRQ) $2.37B
P/E (TTM) -8.2
EPS (TTM) $-2.54
Revenue (TTM) $0
ROE (TTM) -64.0%
52W Range $12–$30

IMNM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$7M
2023-12-31 → 2025-12-31
EPS$-2.43
2020-12-31 → 2025-12-31
Free Cash Flow$-201M
2020-12-31 → 2025-12-31
Net margin-3060.0%
2020-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend IMNM 5Y avg Peer Median Verdict
P/E (TTM) -8.25Y avg ≈-3.9 ≈-3.9 · ·
P/S 340.75Y avg ≈152.9 ≈152.9 152.8 Overvalued
P/B (MRQ) 4.55Y avg ≈3.3 ≈3.3 4.5 Overvalued
Price / FCF (TTM) -10.85Y avg ≈-16.5 ≈-16.5 · ·
Price / Cash Flow (TTM) -11.45Y avg ≈-17.9 ≈-17.9 · ·
Price / Tangible Book 3.75Y avg ≈3.3 ≈3.3 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -1.3%
Next Report Nov 04, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 19, 2026 $-0.65 $-0.53 -22.0%
March 31, 2026 May 11, 2026 $-0.48 $-0.57 16.3%
Dec. 31, 2025 $-0.76 $-0.61 -23.8%
Sept. 30, 2025 $-0.65 $-0.59 -11.0%
June 30, 2025 $-0.50 $-0.54 7.3%
March 31, 2025 $-0.52 $-0.69 25.1%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 12
Metric Trend 202520242023
Revenue $7M$9M$14M
R&D Expense $177M$130M$23M
SG&A Expense $44M$33M$20M
Operating Expenses $231M$315M$124M
Operating Income $-224M$-306M$-110M
Income Tax $0$0$0
Net Income $-212M$-293M$-107M
EPS (Basic) $-2.43$-5.00$-5.38
EPS (Diluted) $-2.43$-5.00$-5.38
Shares (Basic) 87,350,95658,639,44119,843,651
Shares (Diluted) 87,350,95658,639,44119,843,651
EBITDA $-222M$-304M$-109M
Balance Sheet 19
Metric Trend 202520242023
Cash & Equivalents $653M$143M$99M
Prepaid Expense $7M$4M$7M
Current Assets $661M$221M$145M
PP&E (Net) $15M$10M$2M
Other Non-current Assets $5M$4M$100.0K
Total Assets $683M$240M$149M
Accounts Payable $3M$14M$3M
Current Liabilities $45M$54M$22M
Capital Leases $4M$5M$1M
Deferred Tax $801.0K$1M$378.0K
Other Non-current Liabilities ··$1M
Total Liabilities $49M$59M$29M
Common Stock $11.0K$6.0K$4.0K
Paid-in Capital $1.36B$697M$343M
Retained Earnings $-728M$-516M$-223M
AOCI $0$57.0K$22.0K
Stockholders' Equity $634M$181M$120M
Liabilities + Equity $683M$240M$149M
Shares Outstanding 113,133,19964,460,82943,251,778
Cash Flow 11
Metric Trend 202520242023
D&A $2M$2M$457.0K
Stock-based Comp $26M$16M$6M
Other Non-cash $-7M$165M$93M
Operating Cash Flow $-191M$-111M$-8M
CapEx $10M$7M$831.0K
Investing Cash Flow $61M$-85M$-30M
Stock Issued $46M$20M$34.0K
Net Stock Activity $46M$20M$34.0K
Financing Cash Flow $640M$241M$116M
Net Change in Cash $510M$45M$78M
Free Cash Flow $-201M$-118M$-8M
Profitability 5
Metric Trend 202520242023
Operating Margin -3228.8%-3382.4%-781.4%
Net Margin -3060.0%-3240.4%-761.9%
EBITDA Margin -3193.3%-3365.0%-778.1%
ROA -46.0%-150.7%-123.8%
ROE -47.0%-147.9%-169.6%
Liquidity & Solvency 2
Metric Trend 202520242023
Current Ratio 14.74.16.6
Quick Ratio 14.52.64.5
Efficiency 1
Metric Trend 202520242023
Asset Turnover 0.00.00.2
Per Share 5
Metric Trend 202520242023
Book Value / Share $5.61$2.81$2.77
Revenue / Share $0.08$0.15$0.71
Cash Flow / Share $-2.19$-1.89$-0.38
Cash / Share $5.78$2.22$2.28
EPS (TTM) $-2.43$-5.00$-5.38
Growth Rates 1
Metric Trend 202520242023
Revenue YoY -23.2%-35.5%·
Valuation (TTM) 10
Metric Trend 202520242023
Revenue TTM $7M$9M$14M
Net Income TTM $-212M$-293M$-107M
Market Cap $2.43B$685M$463M
P/E -8.8-2.1-2.0
P/S 350.175.733.0
P/B 3.83.83.9
P / Tangible Book 3.83.83.9
P / Cash Flow -12.7-6.2-61.2
P / FCF -12.1-5.8-55.1
Earnings Yield -11.3%-47.1%-50.3%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $7M $9M $14M · ·
Operating Margin % -3228.8% -3382.4% -781.4% -738020.0% 252040.0%
Net Income $-212M $-293M $-107M $-37M $-25M
Diluted EPS $-2.43 $-5.00 $-5.38 $-3.09 $-2.14

Institutional owners (13F) 216 filers · $2.2B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 216
Value held $2.2B
New positions 30
Exited positions 27
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
30 (-22 vs prior Q) 27 (-1 vs prior Q) 75 (+1 vs prior Q) 63 (+15 vs prior Q) +81K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
FMR LLC $359,966,248 16,987,553 16.40% Shares
BlackRock, Inc. $186,588,376 8,805,492 8.50% Shares
VANGUARD GROUP INC $129,705,133 6,038,414 5.91% Shares
STATE STREET CORP $116,431,104 5,494,625 5.30% Shares
WELLINGTON MANAGEMENT GROUP LLP $110,404,477 5,210,216 5.03% Shares
Redmile Group, LLC $104,076,592 4,911,590 4.74% Shares
PRIMECAP MANAGEMENT CO/CA/ $97,080,523 4,581,431 4.42% Shares
VANGUARD CAPITAL MANAGEMENT LLC $96,441,814 4,551,289 4.39% Shares
Driehaus Capital Management LLC $92,094,685 4,346,139 4.20% Shares
ENAVATE SCIENCES GP, LLC $76,576,401 3,613,799 3.49% Shares
GEODE CAPITAL MANAGEMENT, LLC $58,387,674 2,754,889 2.66% Shares
MORGAN STANLEY $51,024,322 2,407,942 2.32% Shares
SILVERARC CAPITAL MANAGEMENT, LLC $42,740,421 2,017,009 1.95% Shares
JPMORGAN CHASE & CO $38,989,792 1,848,548 1.78% Shares
Sofinnova Investments, Inc. $36,453,496 1,720,316 1.66% Shares
READYSTATE ASSET MANAGEMENT LP $34,027,326 1,605,820 1.55% Shares
GOLDMAN SACHS GROUP INC $32,049,642 1,512,489 1.46% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $28,584,865 1,348,979 1.30% Shares
PRINCIPAL FINANCIAL GROUP INC $28,550,515 1,347,358 1.30% Shares
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $26,493,328 1,250,275 1.21% Shares
Woodline Partners LP $21,198,434 1,000,398 0.97% Shares
NORTHERN TRUST CORP $20,519,253 968,346 0.93% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $18,778,430 886,193 0.86% Shares
MetLife Investment Management, LLC $18,203,820 859,076 0.83% Shares
JANUS HENDERSON GROUP PLC $17,672,168 808,019 0.81% Shares
VANGUARD FIDUCIARY TRUST CO $16,025,933 756,297 0.73% Shares
Pivotal bioVenture Partners Investment Advisor LLC $15,521,929 732,512 0.71% Shares
TD Asset Management Inc $15,241,374 719,272 0.69% Shares
NAN FUNG TRINITY (HK) LTD $15,141,378 714,553 0.69% Shares
Candriam S.C.A. $14,398,131 680,132 0.66% Shares
BANK OF AMERICA CORP /DE/ $13,728,746 647,888 0.63% Shares
Parkman Healthcare Partners LLC $12,591,140 594,202 0.57% Shares
MARSHALL WACE, LLP $10,606,379 500,537 0.48% Shares
Qube Research & Technologies Ltd $9,306,351 439,186 0.42% Shares
ALERUS FINANCIAL NA $8,124,691 383,421 0.37% Shares
Granahan Investment Management, LLC $8,021,305 378,542 0.37% Shares
DIMENSIONAL FUND ADVISORS LP $7,796,866 367,967 0.36% Shares
BNP PARIBAS FINANCIAL MARKETS $7,623,738 359,780 0.35% Shares
Rock Springs Capital Management LP $7,367,043 347,666 0.34% Shares
UBS Group AG $6,960,767 328,493 0.32% Shares
Bank of New York Mellon Corp $6,332,970 298,866 0.29% Shares
Atom Investors LP $6,303,792 297,489 0.29% Shares
Nuveen, LLC $6,122,258 288,922 0.28% Shares
KENNEDY CAPITAL MANAGEMENT LLC $5,870,986 277,064 0.27% Shares
Atika Capital Management LLC $5,570,851 262,900 0.25% Shares
FIRST TRUST ADVISORS LP $5,569,219 262,823 0.25% Shares
RENAISSANCE TECHNOLOGIES LLC $5,320,851 251,102 0.24% Shares
Universal- Beteiligungs- und Servicegesellschaft mbH $4,913,134 231,861 0.22% Shares
CITADEL ADVISORS LLC $4,748,234 224,079 0.22% Shares
Burkehill Global Management, LP $4,238,000 200,000 0.19% Shares

Show all 216 institutional owners →

Activists & 5%+ owners 5 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Enavate Sciences GP, LLC, Immunome Aggregator, LP Dec. 22, 2025 4.30% Amendment · SEC
Immunome Aggregator, LP, Enavate Sciences GP, LLC Feb. 4, 2025 6.00% Amendment · SEC
Arsenal Bridge Venture II, LLC, Arsenal Bridge Venture II-B, LLC, Arsenal Bridge Advisors, LLC, RBP Catalyst Fund, L.P., Research Bridge Partners, Inc., Isaac Barchas, James Graham ×2 filings Aug. 21, 2024 · Initial filing · SEC
Undisclosed reporting person Oct. 12, 2023 · Initial filing Passive investment SEC
Morphimmune Inc. July 7, 2023 · Initial filing M&A / sale SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 27 insiders · 14 officers · 14 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Clay B Siegall President and CEO July 23, 2026 A 870,704 4 0 $1,749,659
Purnanand D Sarma President and CEO June 8, 2023 A 10,500 0 0 $0
Max Rosett Chief Financial Officer July 23, 2026 A 101,287 0 3 $-2,518,716
Corleen M. Roche Chief Financial Officer June 8, 2023 A · 0 0 $0
Richard F Fitzgerald Chief Financial Officer Oct. 1, 2020 A · 0 0 $0
Jack Higgins Chief Scientific Officer Sept. 11, 2026 M 56,250 0 2 $-538,462
Kinney Horn CHIEF BUSINESS OFFICER Aug. 4, 2026 M 0 0 2 $-2,300,855
Philip Tsai Chief Technical Officer July 23, 2026 A 81,550 1 0 $204,900
Robert Lechleider Chief Medical Officer July 23, 2026 A 69,805 0 5 $-2,335,993
Sandra G. Stoneman CHIEF LEGAL OFFICER & GC July 23, 2026 A 43,805 0 0 $0
Bruce Turner Chief Strategy Officer Aug. 9, 2024 A 42,300 0 0 $0
Phil Noland Roberts Chief Technology Officer Dec. 13, 2023 A · 0 0 $0
Matthew K Robinson Chief Technology Officer June 8, 2023 A · 0 0 $0
Dennis H Giesing Chief Development Officer June 8, 2023 A · 0 0 $0
Isaac Barchas Director Aug. 12, 2026 S 92,211 0 12 $-18,274,988
James P Boylan Director June 10, 2026 A · 0 0 $0
Sandra M Swain Director June 10, 2026 A · 0 0 $0
Philip Wagenheim Director June 10, 2026 A 341,147 0 2 $-1,335,626
Carol Schafer Director June 10, 2026 A · 0 0 $0
Jean Jacques Bienaime Director June 10, 2026 A 43,415 6 2 $147,610
Michael Rapp Director Oct. 2, 2023 A 1,071,172 0 0 $0
Franklyn G Prendergast Director Oct. 2, 2023 A 60,840 0 0 $0
Michael Lefenfeld Director June 8, 2023 A 40,747 0 0 $0
Richard A Baron Director June 8, 2023 A 2,343 0 0 $0
John L Lamattina Director June 8, 2023 A 66,953 0 0 $0
Michael Widlitz Director May 28, 2021 A 51,315 0 0 $0
Wistar I Morris III 10% owner Oct. 6, 2020 C 38,464 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 30 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
BBC · ETFis Series Trust I 0.83% 16,911 NS July 31, 2026 N-PORT
LABU · Direxion Shares ETF Trust 0.47% 101,669 NS July 31, 2026 N-PORT
IWO · iShares Trust 0.17% 990,362 SH Sept. 11, 2026 Daily
VFMO · VANGUARD WELLINGTON FUND 0.14% 127,656 SH Aug. 19, 2026 Daily
PWS · Pacer Funds Trust 0.13% 1,389 NS July 31, 2026 N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS 0.13% 113,000 SH Aug. 19, 2026 Daily
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0.09% 26,776 NS July 31, 2026 N-PORT
IWM · iShares Trust 0.09% 2,695,157 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.08% 50,465 NS July 31, 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.07% 606,588 SH Aug. 19, 2026 Daily
ESML · iShares Trust 0.06% 67,982 SH Sept. 11, 2026 Daily
ISCG · iShares Trust 0.05% 17,382 SH Sept. 11, 2026 Daily
FHLC · FIDELITY COVINGTON TRUST 0.03% 43,948 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.03% 1,223,884 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.03% 272,423 SH Aug. 19, 2026 Daily
WSML · iShares Trust 0.02% 5,712 SH Sept. 11, 2026 Daily
DFAS · Dimensional ETF Trust 0.02% 105,802 NS July 31, 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.01% 15,698 SH Oct. 1, 2026 Daily
DCOR · Dimensional ETF Trust 0.01% 7,308 NS July 31, 2026 N-PORT
DFSU · Dimensional ETF Trust 0.00% 4,072 NS July 31, 2026 N-PORT
IWV · iShares Trust 0.00% 31,476 SH Sept. 11, 2026 Daily
ITOT · iShares Trust 0.00% 145,382 SH Sept. 11, 2026 Daily
DFAC · Dimensional ETF Trust 0.00% 79,397 NS July 31, 2026 N-PORT
DFAU · Dimensional ETF Trust 0.00% 16,375 NS July 31, 2026 N-PORT
TILT · FlexShares Trust 0.00% 2,754 NS July 31, 2026 N-PORT
DFUS · Dimensional ETF Trust 0.00% 23,366 NS July 31, 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0.00% 3,225,694 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 8,523 SH Aug. 19, 2026 Daily
ISCB · iShares Trust · 4,411 SH Sept. 11, 2026 Daily
ISCV · iShares Trust · 9,397 SH Sept. 11, 2026 Daily

IMNM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 20 analysts BUY
Median target $36.00 +72.2%
5 25.0% Strong Buy
14 70.0% Buy
1 5.0% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

14 analysts · 2026-09-29

Mean target $36.00 +72.2%

← Below all targets Current price $20.90
Low$30.00 Mean$36.00 High$40.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
IMNM $2.43B -8.8 -23.2% -3060.0% -47.0% ·
CLDX $1.81B -7.0 -78.0% -16748.0% -43.8% ·
BEAM $2.82B -34.2 120.0% -57.2% -7.0% ·
IRON $3.01B -13.2 · · -31.3% ·
NRIX $1.80B -5.8 53.9% -314.9% -53.6% ·
SLS $577M -15.1 · · -55.4% ·
VRDN $3.17B -7.7 23359.9% -483.6% -55.4% ·
ADMA $4.34B 30.4 19.6% 28.8% 33.6% 57.4%
RXRX $2.16B -2.8 26.9% -863.4% -62.9% ·

Latest News Recent headlines mentioning this company

23
What Offers Immunome (IMNM) a Compelling Investment Opportunity? Yahoo Finance · 4 months, 2 weeks ago Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More Nasdaq · 5 months, 4 weeks ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 11, 2026